Literature DB >> 22896673

Balancing tissue and tumor formation in regenerative medicine.

Alexander M Bailey1.   

Abstract

A set of general principles can guide preclinical testing strategies for evaluating the tumorigenicity of regenerative medicine products.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22896673     DOI： 10.1126/scitranslmed.3003685

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  20 in total

Review 1.  Concise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturing.

Authors:  Shannon Eaker; Myriam Armant; Harvey Brandwein; Scott Burger; Andrew Campbell; Carmine Carpenito; Dominic Clarke; Timothy Fong; Ohad Karnieli; Knut Niss; Wouter Van't Hof; Ravenska Wagey
Journal:  Stem Cells Transl Med       Date:  2013-10-07       Impact factor: 6.940

2.  An FDA perspective on preclinical development of cell-based regenerative medicine products.

Authors:  Alexander M Bailey; Michael Mendicino; Patrick Au
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

3.  The Role of Nonhuman Primate Animal Models in the Clinical Development of Pluripotent Stem Cell Therapies.

Authors:  So Gun Hong; Yongshun Lin; Cynthia E Dunbar; Jizhong Zou
Journal:  Mol Ther       Date:  2016-08       Impact factor: 11.454

Review 4.  Advances in translational orthopaedic research with species-specific multipotent mesenchymal stromal cells derived from the umbilical cord.

Authors:  Melina Ramallo; Irene Carreras-Sánchez; Alba López-Fernández; Roberto Vélez; Màrius Aguirre; Sara Feldman; Joaquim Vives
Journal:  Histol Histopathol       Date:  2020-09-11       Impact factor: 2.303

Review 5.  Current status of pluripotent stem cells: moving the first therapies to the clinic.

Authors:  Erin A Kimbrel; Robert Lanza
Journal:  Nat Rev Drug Discov       Date:  2015-09-22       Impact factor: 84.694

6.  Protocatechuic acid benefits proliferation and phenotypic maintenance of rabbit articular chondrocytes: An in vitro study.

Authors:  Like Luo; Qingjun Wei; Lei Liu; Xiao Lin; Cuiwu Lin; L I Zheng; Jinmin Zhao
Journal:  Exp Ther Med       Date:  2015-03-02       Impact factor: 2.447

7.  Is a Part Better than the Whole for Cell-based Therapy for Acute Respiratory Distress Syndrome?

Authors:  Jae W Lee; Michael A Matthay
Journal:  Anesthesiology       Date:  2019-05       Impact factor: 8.986

Review 8.  Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products.

Authors:  Shin Kawamata; Hoshimi Kanemura; Noriko Sakai; Masayo Takahashi; Masahiro J Go
Journal:  J Clin Med       Date:  2015-01-14       Impact factor: 4.241

9.  Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration.

Authors:  Hoshimi Kanemura; Masahiro J Go; Masayuki Shikamura; Naoki Nishishita; Noriko Sakai; Hiroyuki Kamao; Michiko Mandai; Chikako Morinaga; Masayo Takahashi; Shin Kawamata
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

Review 10.  Human Mesenchymal Stromal Cells from Different Sources Diverge in Their Expression of Cell Surface Proteins and Display Distinct Differentiation Patterns.

Authors:  Kourosch C Elahi; Gerd Klein; Meltem Avci-Adali; Karl D Sievert; Sheila MacNeil; Wilhelm K Aicher
Journal:  Stem Cells Int       Date:  2015-12-06       Impact factor: 5.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.